Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226339036> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4226339036 endingPage "524" @default.
- W4226339036 startingPage "519" @default.
- W4226339036 abstract "Introduction
 Pethidine along with morphine and tramadol, is one of the frequently used drugs for postoperative pain management. It is important to ensure the safety of the product and ultimately the safety of the patients as users of the pethidine.
 Methods
 A post marketing surveillance study was conducted with a retrospective cross-sectional design using medical records and hospital pharmacy’s data in patients who were admitted to inpatient or emergency department of Dr. Sardjito General Hospital Yogyakarta between January and December 2016. The data was analyzed descriptively to estimate the proportion of adverse events (AEs) including serious adverse events (SAE).
 Results
 Of the 576 patients hospitalized at the at the Dr. Sardjito General Hospital, 200 medical records were selected using consecutive sampling method. A total of 120 of the 200 subjects were found to have 245 any Adverse Events (AE) including Serious Adverse Events (SAE) following the administration of pethidine. There were 23 classifications of expected AE and 148 classifications of unexpected AE following the administration of pethidine. The duration of AE/SAE found ranged from 0 to 11 days. A total of 101 (50.5%) and 85 (42.5%) subjects experienced AE/SAE with duration <24 hours and between 1 to 2 days, respectively. The longest duration of event was pain with duration of 11 days. There were 23 types of expected AE/SAE from pethidine found in subjects, with the highest number of expected AE/SAE were weakness, vomiting, and dizziness of 24 (25%), 16 (16.8%), and 10 (10.5%), respectively. The expert panel team concluded five types of unexpected SAEs which are possible to pethidine, including respiratory acidosis, urinary tract infections, acute kidney injury, icteric, and electrolyte imbalance.
 Conclusion
 A post-marketing surveillance study provides safety profile of 50 mg / ml pethidine in Indonesia. A total of 120 of the 200 subjects who received pethidine experienced 245 Adverse Events (AEs) or Serious Adverse Events (SAEs). AEs/SAEs were divided into 23 types of expected events and 148 types of unexpected events. Few numbers of SAEs were considered possible related to the pethidine according to expert panel review.
 
 Keywords: pethidine, meperidine, post-marketing, pharmacovigilance" @default.
- W4226339036 created "2022-05-05" @default.
- W4226339036 creator A5000527970 @default.
- W4226339036 creator A5001371261 @default.
- W4226339036 creator A5014553304 @default.
- W4226339036 creator A5015581800 @default.
- W4226339036 creator A5024236180 @default.
- W4226339036 creator A5029386237 @default.
- W4226339036 creator A5040150442 @default.
- W4226339036 creator A5060189845 @default.
- W4226339036 creator A5061550667 @default.
- W4226339036 creator A5062931140 @default.
- W4226339036 creator A5063358538 @default.
- W4226339036 creator A5066425085 @default.
- W4226339036 date "2022-03-19" @default.
- W4226339036 modified "2023-10-18" @default.
- W4226339036 title "A Post-Marketing Study of Pethidine in Indonesia: Safety Profile" @default.
- W4226339036 doi "https://doi.org/10.3889/oamjms.2022.8526" @default.
- W4226339036 hasPublicationYear "2022" @default.
- W4226339036 type Work @default.
- W4226339036 citedByCount "0" @default.
- W4226339036 crossrefType "journal-article" @default.
- W4226339036 hasAuthorship W4226339036A5000527970 @default.
- W4226339036 hasAuthorship W4226339036A5001371261 @default.
- W4226339036 hasAuthorship W4226339036A5014553304 @default.
- W4226339036 hasAuthorship W4226339036A5015581800 @default.
- W4226339036 hasAuthorship W4226339036A5024236180 @default.
- W4226339036 hasAuthorship W4226339036A5029386237 @default.
- W4226339036 hasAuthorship W4226339036A5040150442 @default.
- W4226339036 hasAuthorship W4226339036A5060189845 @default.
- W4226339036 hasAuthorship W4226339036A5061550667 @default.
- W4226339036 hasAuthorship W4226339036A5062931140 @default.
- W4226339036 hasAuthorship W4226339036A5063358538 @default.
- W4226339036 hasAuthorship W4226339036A5066425085 @default.
- W4226339036 hasBestOaLocation W42263390361 @default.
- W4226339036 hasConcept C104863432 @default.
- W4226339036 hasConcept C126322002 @default.
- W4226339036 hasConcept C141071460 @default.
- W4226339036 hasConcept C194828623 @default.
- W4226339036 hasConcept C195910791 @default.
- W4226339036 hasConcept C197934379 @default.
- W4226339036 hasConcept C2779777798 @default.
- W4226339036 hasConcept C2780580376 @default.
- W4226339036 hasConcept C2780820201 @default.
- W4226339036 hasConcept C2780852908 @default.
- W4226339036 hasConcept C2781168792 @default.
- W4226339036 hasConcept C42219234 @default.
- W4226339036 hasConcept C512399662 @default.
- W4226339036 hasConcept C71924100 @default.
- W4226339036 hasConceptScore W4226339036C104863432 @default.
- W4226339036 hasConceptScore W4226339036C126322002 @default.
- W4226339036 hasConceptScore W4226339036C141071460 @default.
- W4226339036 hasConceptScore W4226339036C194828623 @default.
- W4226339036 hasConceptScore W4226339036C195910791 @default.
- W4226339036 hasConceptScore W4226339036C197934379 @default.
- W4226339036 hasConceptScore W4226339036C2779777798 @default.
- W4226339036 hasConceptScore W4226339036C2780580376 @default.
- W4226339036 hasConceptScore W4226339036C2780820201 @default.
- W4226339036 hasConceptScore W4226339036C2780852908 @default.
- W4226339036 hasConceptScore W4226339036C2781168792 @default.
- W4226339036 hasConceptScore W4226339036C42219234 @default.
- W4226339036 hasConceptScore W4226339036C512399662 @default.
- W4226339036 hasConceptScore W4226339036C71924100 @default.
- W4226339036 hasIssue "A" @default.
- W4226339036 hasLocation W42263390361 @default.
- W4226339036 hasOpenAccess W4226339036 @default.
- W4226339036 hasPrimaryLocation W42263390361 @default.
- W4226339036 hasRelatedWork W1524807405 @default.
- W4226339036 hasRelatedWork W1996623542 @default.
- W4226339036 hasRelatedWork W2070683333 @default.
- W4226339036 hasRelatedWork W2350892925 @default.
- W4226339036 hasRelatedWork W2351238419 @default.
- W4226339036 hasRelatedWork W2353947177 @default.
- W4226339036 hasRelatedWork W2358248846 @default.
- W4226339036 hasRelatedWork W2363131243 @default.
- W4226339036 hasRelatedWork W2380476321 @default.
- W4226339036 hasRelatedWork W2387196259 @default.
- W4226339036 hasVolume "10" @default.
- W4226339036 isParatext "false" @default.
- W4226339036 isRetracted "false" @default.
- W4226339036 workType "article" @default.